{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002421","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001365688","attributes":{"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY":["H3K27ac"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"4 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["214"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor NGS (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S017B9/Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"670M","NAME":"S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160226.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S017B9/Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160226.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"0b01101e83c3319c6675e191f93b0892"},{"FORMAT":"bigBed","SIZE":"860K","NAME":"S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160310.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S017B9/Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160310.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"99c1f0621c416252db3b54b4438d8c85"},{"FORMAT":"BED","SIZE":"961K","NAME":"S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160310.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S017B9/Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160310.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"b56d065757951cbef39bbdeba3155d46"},{"FORMAT":"Text","SIZE":"1.1M","NAME":"S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160310.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S017B9/Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S017B9H1.ERX1304154.H3K27ac.bwa.GRCh38.20160310.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"58ae6b9f97dd0f8ad7d34f3d0226a2f7"}],"dataset_id":"EGAD00001002421","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"S017B9","sample_barcode":"S017B9H1","attributes":{"DISEASE":["Acute Lymphocytic Leukemia"],"CELL_TYPE":["precursor B cell"],"DISEASE_ONTOLOGY_URI":[{"url":"9","label":"C0023449"}],"SAMPLE_ONTOLOGY_URI":[{"url":"7","label":"CL_0000817"}],"GENDER":["unknown"],"DONOR_ID":["S017B9"],"SEX":["unknown"],"MARKERS":["NA"],"DONOR_HEALTH_STATUS":["Acute Lymphocytic Leukemia"],"MOLECULE":["genomic DNA"],"DONOR_AGE":["0 - 18"],"BIOMATERIAL_PROVIDER":["Anke Bergmann"],"TISSUE_TYPE":["venous blood"],"BIOMATERIAL_TYPE":["Primary Cell"],"SUBJECT_ID":["S017B9"],"DONOR_SEX":["Unknown"],"DONOR_ETHNICITY":["NA"]},"SAMPLE_ID":"EGAN00001360029","SAMPLE_DESCRIPTION":"Acute Lymphocytic Leukemia"}}